智通财经APP获悉，剂泰科技-P(07666)涨近5%，截至发稿，涨4.47%，报15.44港元，成交额822.35万港元。
消息面上，5月28日，据剂泰科技官微消息，公司宣布与全球顶级健康投资与创新平台Deerfield Management(以下简称“Deerfield”)达成战略联盟。双方将共同开发新一代体内蛋白药物(in vivo protein therapeutics)及免疫疗法，并共同推进合作管线产品的全球商业化进程。
Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。其中包括剂泰科技自研AiProtein平台发现并推进至临床前候选药物(PCC)阶段的一项领先T细胞衔接器(T-cell engager, TCE)项目。Deerfield将进一步探索该项目潜在授权与开发机会，以推动其进入IND支持性研究和临床开发阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.